Takeda: Maribavir Gets Positive CHMP Opinion To Treat Post-transplant Cytomegalovirus Refractory
BRUSSELS (dpa-AFX) - Takeda Pharmaceutical Co. Ltd. (TAK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has recommended the approval